Tag: Alladapt Immunotherapeutics

Clinical Trial

Broad Spectrum OIT Candidate for Multiple Food Allergies Begins Phase 1/2...

The Harmony Study plans to enroll patients across 20 sites in the United States.
Alladapt

Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...

Company is developing therapy to target a number of food allergies simultaneously.